What's happening with the ResMed share price on Wednesday?

The ResMed share price is facing some quarterly headwinds today.

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price is edging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $29.30. In morning trade on Wednesday, shares are swapping hands for $29.34, up 0.1%.

For some context, the ASX 200 is up 0.6% at this same time.

Here's what's happening.

What's going on with the ASX 200 healthcare company?

The ResMed share price may be trailing the ASX 200 because the sleep treatment company's stock is trading ex-dividend today.

That means investors who buy the stock today will no longer be eligible for the 4.8 US cents per share unfranked dividend.

That passive income payout will go to investors who held ResMed shares at market close yesterday. Eligible investors can expect to see this hit their bank accounts on 14 March.

The company will report on the Aussie dollar equivalent for ASX investors on Friday, 9 February. (At time of writing AU$1 is worth 65.3 US cents.)

It's common for stocks to face some headwinds on the day they trade ex-dividend. All else being equal, the ResMed share price is now factored in at 4.8 US cents less than it would have been yesterday.

Unlike most ASX 200 stocks, ResMed pays dividends on a quarterly basis.

In the quarter just past, the company paid US$70.7 million in dividends. It also repurchased 335,000 shares for US$50 million as part of ResMed's ongoing capital management.

Overall, it was a strong quarter for the company, with revenue up 12% year on year (11% on a constant currency basis) to US$1.2 billion. And profits were well up, with non-GAAP operating profit leaping 20%.

Commenting on the outlook for the sleep treatment company on the day it reported, CEO Mick Farrell said, "ResMed is well-positioned to lean into leading the expansion and growth of sleep health and breathing health. We are the clear leader in a very large and growing market."

ResMed share price snapshot

The steep falls in August and September see the ResMed share price down 7% over 12 months.

Shares have soared 37% since the lows on 25 September.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

Dividend Investing

How I'd start earning passive income to replace my wages

Want to give up work? Here's a long term plan you can put into action.

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Dividend Investing

3 ASX dividend shares to buy after Christmas

Why are analysts bullish on these income options? Let's find out what they are saying.

Read more »

Dividend Investing

These buy-rated ASX dividend stocks offer 4% to 7% yields

Brokers think that income investors should be buying these top income options right now.

Read more »

man dressed as santa holding a piggy bank
Dividend Investing

Buy these ASX dividend shares as Christmas presents

Here's why they could be in the buy zone.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Dividend Investing

A 10% dividend yield from an All Ords stock with a forward P/E of 9!

I’m bullish on this stock. Here’s why.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Dividend Investing

I'd buy these ASX dividend shares with big yields for income

These are some of the most appealing businesses to me for a big yield.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Dividend Investing

15 ASX 200 stocks going ex-dividend before New Year's Eve

Looking for some last minute end-of-year dividend income? Better be quick.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Dividend Investing

Top analysts say these ASX 200 dividend shares are great buys

Here's what analysts are saying about these income options right now.

Read more »